Société Générale : The downward trend should continue
Entry price | Target | Stop-loss | Potential |
---|
€35.31 |
€29 |
€38.2 |
+17.86% |
---|
The technical chart pattern of stocks in Société Générale suggests a continuation of the underlying downward trend, which has already been in place for a number of trading sessions.
Strengths● The share is getting closer to its long-term support in weekly data, at EUR 35.24, which offers good timing for buyers.
● Graphically speaking, the timing seems perfect for purchasing the stock close to the EUR 35.24 support.
● The group's activity appears highly profitable thanks to its outperforming net margins.
● Historically, the company has been releasing figures that are above expectations.
● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
● The company is one of the best yield companies with high dividend expectations.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses● According to forecast, a sluggish sales growth is expected for the next fiscal years.
● The technical configuration over the long term remains negative on the weekly chart below the resistance level at 41.96 EUR
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.